2012 annual financial data
Atossa Therapeutics 2012 Operating margin
Atossa Therapeutics 2012 operating margin with verified reported values.
Direct answer
Operating margin was -1,052.01%.
Operating income was -5,069,030 USD and net income was -5,079,851 USD.
Operating cash flow was -3,899,964 USD.
Get free Atossa Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 481,842 USD
- Operating income
- -5,069,030 USD
- Net income
- -5,079,851 USD
- Operating cash flow
- -3,899,964 USD